Effective July 1, 2025, Aetna will no longer cover Zepbound, a GLP-1 medication used for weight management
Additionally, over three times the number of people taking the drug achieved a 5% reduction, a generally accepted baseline for clinically meaningful weight loss
These foods are associated with anti-diabetic, anti-hypertensive, and neuroprotective effects (129, 130)
This was a 52-week trial with a 26-week extension among children (10 17 years of age) with uncontrolled T2D (HbA1c 6.5 - 10.5%) receiving metformin, insulin, or both
For most patients comparing options, the semaglutide out-of-pocket cost comes down to one decision: brand-name at pharmacy list price or compounded through a supervised provider Insurance is more likely to cover semaglutide when it is prescribed for type 2 diabetes management
With a focus on patient education, empowerment, and personalized care, Dr